GO:0046642 negative regulation of alpha-beta T cell proliferation: Immune Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046642 describes the biological process that reduces the rate or extent of alpha-beta T cell proliferation, a key checkpoint in adaptive immunity [2,6].
• Alpha-beta T cells are defined by a T cell receptor (TCR) composed of alpha and beta chains, and their proliferation must be tightly controlled to prevent autoimmunity and lymphoproliferative disease [3,4,8].
• Negative regulation can be cell-intrinsic (e.g., GSK-3 kinase activity, Notch/RBP-J signaling) or cell-extrinsic (e.g., PD-L1/PD-1 axis, interleukin-7 deprivation) [1,2,6,7].
• Dysregulation of this process is linked to cancer immune evasion, autoimmune disorders, and abnormal lymphoproliferation [1,2,5].
• Key experimental approaches include knockout and knock-in mouse models, TCR signaling assays, and CRISPR-based screens [2,6,7].
• Understanding GO:0046642 provides a framework for developing immunotherapies that modulate T cell expansion [1,6].
Description
The Gene Ontology (GO) term GO:0046642, negative regulation of alpha-beta T cell proliferation, defines any process that stops, prevents, or reduces the frequency, rate, or extent of alpha-beta T cell proliferation [2,6]. Alpha-beta T cells constitute the majority of T lymphocytes and are characterized by a T cell receptor (TCR) heterodimer of alpha and beta chains [3,4]. Their controlled expansion is essential for effective immune responses against pathogens while preventing excessive inflammation and autoimmunity. This GO term is therefore central to understanding adaptive immune homeostasis. Researchers study this process to identify molecular brakes that can be harnessed for cancer immunotherapy or targeted to treat autoimmune diseases [1,2]. The term encompasses both intrinsic signaling pathways, such as GSK-3 kinase activity, and extrinsic regulatory mechanisms, including checkpoint inhibition via PD-L1/PD-1 and cytokine deprivation [1,2,7]. Because alpha-beta T cell proliferation is a hallmark of adaptive immunity, its negative regulation is a critical node for therapeutic intervention [6,8].
negative regulation of alpha-beta T cell proliferation At A Glance
| GO ID | GO:0046642 |
|---|---|
| GO term | negative regulation of alpha-beta T cell proliferation |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Suppresses the expansion of alpha-beta T cells to maintain immune homeostasis and prevent autoimmunity [2,6] |
| Related processes | T cell activation, TCR signaling, cytokine signaling, immune checkpoint regulation [1,2,7] |
| Key regulators | GSK-3, Notch/RBP-J, PD-L1/PD-1, IL-7 [1,2,6,7] |
| Disease relevance | Cancer, autoimmunity, lymphoproliferative disorders [1,2,5] |
What Is GO:0046642?
In our own words, GO:0046642 refers to any biological process that decreases the rate, extent, or frequency of proliferation of alpha-beta T cells. These cells express a TCR composed of alpha and beta chains and are the primary mediators of cellular adaptive immunity [3,4]. Negative regulation can occur through intrinsic cell-cycle inhibitors, inhibitory signaling pathways, or extrinsic factors that limit survival or activation signals [2,6,7].
Why Is negative regulation of alpha-beta T cell proliferation Important in Cell Biology?
Negative regulation of alpha-beta T cell proliferation is essential for balancing protective immunity and immune tolerance. Without adequate brakes, T cells can expand uncontrollably, leading to autoimmunity or lymphoma, while excessive suppression can permit tumor immune evasion or impair pathogen clearance [1,2,5]. Understanding this process informs the development of immunotherapies, including checkpoint inhibitors and modulators of T cell exhaustion [1,6].
• Prevents autoimmunity by limiting self-reactive alpha-beta T cell expansion [2,6].
• Controls lymphoproliferative disorders and leukemia development.
• Regulates immune responses to infections and tumors [1,7].
• Influences the efficacy of cancer immunotherapy (e.g., PD-1/PD-L1 blockade).
• Modulates T cell homeostasis and memory formation.
• Provides targets for treating autoimmune diseases such as multiple sclerosis and type 1 diabetes [2,6].
• Impacts vaccine design by shaping T cell expansion kinetics.
• Serves as a model for studying cell cycle control in lymphocytes.
What Happens During negative regulation of alpha-beta T cell proliferation?
Intrinsic Signaling Brakes
In simple terms: Inside the T cell, certain molecules act like brakes on cell division.
Cell-intrinsic negative regulators include the serine/threonine kinase GSK-3, which suppresses T cell proliferation and interleukin-2 production upon TCR stimulation. Notch/RBP-J signaling also modulates peripheral T cell responses and can limit alpha-beta T cell expansion. These pathways intersect with cell cycle machinery to halt progression.
Extrinsic Inhibitory Signals
In simple terms: Signals from outside the T cell can tell it to stop multiplying.
The PD-L1/PD-1 axis delivers inhibitory signals that suppress alpha-beta T cell proliferation, a mechanism exploited by tumors for immune evasion. Interleukin-7 deprivation also negatively regulates human T cell development and proliferation in vitro. These extrinsic cues are critical for maintaining peripheral tolerance.
TCR Affinity and Self-Antigen Recognition
In simple terms: How strongly a T cell's receptor binds to self-antigens can influence whether it multiplies.
Co-expression of two T cell receptors can promote lymphopenia-induced proliferation via increased affinity for self-antigen, but negative regulation may counterbalance this to prevent excessive expansion. TCR signal strength and lineage commitment decisions also affect subsequent proliferative capacity.
Developmental Checkpoints
In simple terms: During T cell development, checkpoints ensure only useful cells multiply.
T cell lineage determination precedes TCR beta gene rearrangement, and negative regulatory mechanisms operate during thymic selection to eliminate self-reactive alpha-beta T cells [4,8]. Notch/RBP-J signaling influences alpha-beta versus gamma-delta lineage commitment and subsequent peripheral responses.
Key Genes Involved in GO:0046642 negative regulation of alpha-beta T cell proliferation
The following genes and proteins have been experimentally implicated in the negative regulation of alpha-beta T cell proliferation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSK3A/GSK3B | Serine/threonine kinases that suppress T cell proliferation and IL-2 production | Target for modulating T cell activation in autoimmunity and cancer |
| RBPJ | Mediator of Notch signaling; regulates alpha-beta/gamma-delta lineage commitment and peripheral T cell responses | Knockout studies reveal its role in limiting T cell expansion |
| PDCD1 (PD-1) | Inhibitory receptor on T cells; engagement by PD-L1 suppresses proliferation | Target for cancer immunotherapy (checkpoint blockade) |
| CD274 (PD-L1) | Ligand for PD-1; delivers inhibitory signals to T cells | Expressed on tumor cells; mediates immune evasion |
| IL7R | Receptor for IL-7; deprivation of IL-7 negatively regulates T cell development and proliferation | Model for cytokine-dependent T cell expansion |
| TCRA (TRA) | T cell receptor alpha chain; part of alpha-beta TCR [3,4] | Defines alpha-beta T cell lineage; mutations affect proliferation |
| TCRB (TRB) | T cell receptor beta chain; rearranged during development | Lineage determination and proliferative capacity |
| CD3E | Signaling component of TCR complex | Required for TCR signal transduction and proliferation |
| NOTCH1 | Notch receptor; influences T cell lineage and peripheral responses | Modulates alpha-beta T cell proliferation |
| NOTCH2 | Notch receptor; contributes to T cell development and regulation | Potential target for modulating T cell expansion |
| IL2 | T cell growth factor; its production is suppressed by GSK-3 | Readout for negative regulation of proliferation |
| FOXP3 | Regulatory T cell transcription factor; suppresses effector T cell proliferation | Key for immune tolerance |
| CTLA4 | Inhibitory receptor; negatively regulates T cell activation and proliferation | Target for autoimmune therapy |
| LAG3 | Inhibitory receptor; limits T cell expansion | Checkpoint target in cancer |
| HAVCR2 (TIM-3) | Inhibitory receptor; suppresses T cell proliferation | Immunotherapy target |
| TGFB1 | Cytokine that inhibits T cell proliferation | Regulates immune suppression |
| IL10 | Anti-inflammatory cytokine; suppresses T cell proliferation | Modulates immune responses |
How Is negative regulation of alpha-beta T cell proliferation Regulated?
Negative regulation of alpha-beta T cell proliferation is controlled by a network of intrinsic and extrinsic factors. GSK-3 kinase activity directly suppresses proliferation and IL-2 production. Notch/RBP-J signaling modulates peripheral T cell responses and lineage commitment. The PD-L1/PD-1 axis provides a major inhibitory checkpoint, and its blockade enhances T cell proliferation. Cytokine availability, such as IL-7 deprivation, also negatively regulates human T cell development. These pathways are integrated with TCR signal strength and developmental checkpoints [4,8].
negative regulation of alpha-beta T cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDCD1 | Cancer immune evasion; autoimmunity | PD-1 knockout mice; tumor challenge models |
| GSK3B | Autoimmunity; lymphoproliferation | GSK-3 knockout or inhibitor-treated T cells |
| RBPJ | T cell lineage commitment defects; immune dysregulation | Conditional RBP-J knockout mice |
| IL7R | Immunodeficiency; T cell lymphopenia | IL-7 deprivation in human T cell cultures |
| TCRA/TCRB | T cell development abnormalities; autoimmunity [3,4] | TCR transgenic and knockout models [3,4] |
Cancer Immune Evasion
Tumors exploit negative regulatory pathways to suppress alpha-beta T cell proliferation. PD-L1 expressed on tumor cells engages PD-1 on T cells, delivering inhibitory signals that impair anti-tumor immunity. Blocking this interaction with checkpoint inhibitors restores T cell proliferation and is a cornerstone of cancer immunotherapy.
Autoimmunity and Lymphoproliferation
Loss of negative regulation can lead to uncontrolled alpha-beta T cell expansion, contributing to autoimmune diseases and lymphoproliferative disorders [2,5]. GSK-3 deficiency results in hyperproliferation and increased IL-2 production, highlighting its role as a brake. Dysregulated TCR signaling and self-antigen recognition can also drive abnormal expansion.
Infectious Disease and Immunodeficiency
Proper negative regulation is required to contract immune responses after pathogen clearance. Interleukin-7 deprivation negatively regulates human T cell development, and dysregulation may contribute to immunodeficiency or chronic inflammation. Notch/RBP-J signaling defects alter peripheral T cell responses and may impact infection outcomes.
From negative regulation of alpha-beta T cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GSK-3 inhibit alpha-beta T cell proliferation? | GSK-3 knockout or kinase-dead knock-in mice |
| How does PD-1 signaling suppress T cell expansion? | PD-1 knockout mice and PD-L1 overexpression tumor models |
| What is the role of Notch/RBP-J in peripheral T cell responses? | Conditional RBP-J knockout mice |
| How does IL-7 deprivation affect human T cell development? | In vitro human T cell cultures with IL-7 withdrawal |
| Does TCR affinity for self-antigen regulate lymphopenia-induced proliferation? | TCR transgenic models with dual TCR expression |
| What developmental checkpoints limit alpha-beta T cell expansion? | RAG-deficient or TCR transgenic mice [4,8] |
How to Study the negative regulation of alpha-beta T cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFSE dilution | Cell division history | Assessing proliferation inhibition by GSK-3 or PD-1 [2,7] |
| Phospho-flow | TCR signaling strength | Evaluating signal thresholds for negative regulation |
| ELISA | Cytokine secretion (IL-2, IFN-γ) | Functional readout of T cell activation [2,8] |
| CRISPR knockout screen | Gene essentiality for proliferation | Identifying novel negative regulators [1,6] |
| RNA-seq | Transcriptional changes | Pathway analysis of anergic or suppressed T cells [1,7] |
| ATAC-seq | Chromatin accessibility | Epigenetic regulation of proliferation genes |
| Immunoblotting | Protein expression and phosphorylation | Validating GSK-3 or Notch signaling [2,6] |
| In vivo tumor models | T cell expansion and tumor control | Testing PD-1/PD-L1 blockade |
Flow Cytometry and CFSE Dilution
Flow cytometry with CFSE or CellTrace Violet labeling measures alpha-beta T cell division history and proliferation index. This method is widely used to assess negative regulation by GSK-3, PD-1, or cytokine deprivation [2,7].
TCR Signaling Assays
Phospho-flow and immunoblotting for TCR signaling intermediates (e.g., CD3ζ, ZAP-70, ERK) quantify signal strength that influences proliferative outcomes [4,6].
Cytokine Production Assays
ELISA or intracellular cytokine staining for IL-2, IFN-γ, and TNF-α provides functional readouts of T cell activation and negative regulation [2,8].
CRISPR Screens
Genome-wide CRISPR knockout screens in primary T cells or Jurkat cells can identify novel negative regulators of alpha-beta T cell proliferation [1,6].
How CRISPR Can Be Used to Study GO:0046642 negative regulation of alpha-beta T cell proliferation
Knockout
CRISPR knockout of negative regulators such as GSK3B, PDCD1, or RBPJ in T cells or mouse models can reveal their role in suppressing alpha-beta T cell proliferation [2,6]. For example, PD-1 knockout enhances T cell expansion and anti-tumor activity.
Point Mutation
Introducing point mutations in kinase domains (e.g., GSK3B) or signaling motifs (e.g., PD-1 ITIM) allows precise dissection of negative regulatory mechanisms without complete gene loss [2,1].
Knock-in
Knock-in of reporters (e.g., IL-2-GFP) or tagged alleles (e.g., GSK3B-FLAG) enables real-time monitoring of negative regulation in primary T cells [2,7].
Overexpression
Overexpression of PD-L1 or constitutively active GSK-3 in T cells or tumor models can model enhanced negative regulation and immune suppression [1,2].
How EDITGENE Supports negative regulation of alpha-beta T cell proliferation Research
Researchers studying negative regulation of alpha-beta T cell proliferation-related genes often need to determine whether a candidate gene is causally involved in suppressing T cell expansion. EDITGENE provides comprehensive CRISPR-based services to interrogate gene function with precision.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of alpha-beta T cell proliferation research.
Frequently Asked Questions About negative regulation of alpha-beta T cell proliferation
What is GO:0046642?
GO:0046642 is the Gene Ontology term for negative regulation of alpha-beta T cell proliferation, describing any process that reduces the rate or extent of alpha-beta T cell division [2,6].
What genes are involved in negative regulation of alpha-beta T cell proliferation?
Key genes include GSK3A/GSK3B, RBPJ, PDCD1 (PD-1), CD274 (PD-L1), IL7R, and NOTCH1/2, among others [1,2,6,7].
How does GSK-3 inhibit T cell proliferation?
GSK-3 is a serine/threonine kinase that suppresses T cell proliferation and interleukin-2 production upon TCR stimulation.
What is the role of PD-1 in T cell proliferation?
PD-1 is an inhibitory receptor that, upon binding PD-L1, delivers signals that suppress alpha-beta T cell proliferation, a mechanism exploited by tumors.
How does Notch signaling regulate alpha-beta T cell proliferation?
Notch/RBP-J signaling influences alpha-beta/gamma-delta lineage commitment and peripheral T cell responses, including negative regulation of proliferation.
Can CRISPR be used to study negative regulation of alpha-beta T cell proliferation?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise interrogation of genes like GSK3B, PDCD1, and RBPJ in T cell proliferation assays [1,2,6].
What diseases are associated with dysregulated alpha-beta T cell proliferation?
Cancer immune evasion, autoimmune diseases, and lymphoproliferative disorders are linked to defects in negative regulation [1,2,5].
How is alpha-beta T cell proliferation measured?
Common methods include CFSE dilution, flow cytometry, and cytokine production assays such as IL-2 ELISA [2,7].
What is the difference between alpha-beta and gamma-delta T cells?
Alpha-beta T cells express a TCR composed of alpha and beta chains, while gamma-delta T cells express gamma and delta chains; they have distinct lineage commitment and functions [3,6].
Why is negative regulation of alpha-beta T cell proliferation important for immunotherapy?
It is critical for preventing autoimmunity and for understanding how tumors evade immune attack; checkpoint inhibitors like anti-PD-1 block negative regulation to enhance T cell proliferation.
Conclusion
GO:0046642, negative regulation of alpha-beta T cell proliferation, is a fundamental biological process that maintains immune homeostasis by restraining T cell expansion. Dysregulation of this process contributes to cancer, autoimmunity, and lymphoproliferative diseases [1,2,5]. Continued research using CRISPR models and advanced immunology methods will uncover new therapeutic targets and deepen our understanding of adaptive immunity [6,7].
References
- 1. Litak J et al.. 2019. PD-L1/PD-1 Axis in Glioblastoma Multiforme.. Int J Mol Sci 20(21) PMID: 31661771
- 2. Ohteki T et al.. 2000. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3.. J Exp Med 192(1):99-104 PMID: 10880530
- 3. Rodríguez-Rodríguez N et al.. 2020. TCR-α/β CD4(-) CD8(-) double negative T cells arise from CD8(+) T cells.. J Leukoc Biol 108(3):851-857 PMID: 32052478
- 4. Masuda K et al.. 2007. T cell lineage determination precedes the initiation of TCR beta gene rearrangement.. J Immunol 179(6):3699-706 PMID: 17785806
- 5. Balakrishnan A et al.. 2018. Endogenous co-expression of two T cell receptors promotes lymphopenia-induced proliferation via increased affinity for self-antigen.. J Leukoc Biol 104(6):1097-1104 PMID: 30168881
- 6. Tanigaki K et al.. 2004. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling.. Immunity 20(5):611-22 PMID: 15142529
- 7. Patel ES et al.. 2012. Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation.. BMC Immunol 13:46 PMID: 22897934
- 8. Rothenberg EV. 1992. The development of functionally responsive T cells.. Adv Immunol 51:85-214 PMID: 1386962
